Agilent Technologies Presents Thought Leader Award to Professor Dwight Stoll for Separation Science Research
April 19 2017 - 11:00AM
Business Wire
Award Supports International Collaboration on Two-Dimensional
Liquid Chromatography
Agilent Technologies Inc. (NYSE: A) announced today that Prof.
Dwight Stoll has received an Agilent Thought Leader Award in
support of his research applying two-dimensional liquid
chromatography (2D-LC) to biopharmaceutical analysis.
An influential researcher in chromatography, Prof. Stoll
specializes in multi-dimensional separations, which enables
scientists to isolate the components of complex samples with
greater ease and clarity.
“I am honored to receive this award, and very excited about
Agilent’s support of the vision of my laboratory and our
collaborators, as we focus on the development of next-generation
analytical tools based on 2D-LC for the biopharmaceutical research
area,” said Prof. Stoll, associate professor of analytical
chemistry at Gustavus Adolphus College in Saint Peter,
Minnesota.
Prof. Stoll will lead a project on the use of 2D-LC in
biopharmaceutical analysis that includes several international
experts: Prof. Michael Lämmerhofer of the University of Tuebingen,
Germany; Dr. Douglas Richardson of Merck Research Laboratories,
Kenilworth, NJ, USA; and Dr. Davy Guillarme of the University of
Geneva, Switzerland.
“We are pleased to support Dr. Stoll’s research using Agilent’s
transformative 2D-LC technology, which has the potential to resolve
key challenges that biopharmaceutical scientists face when
analyzing complex samples,” said Dr. Stefan Schuette, vice
president and general manager Liquid Phase Separations Division at
Agilent Technologies. “The collaborative nature of the research of
Dr. Stoll and his international colleagues, combining both academia
and industry, will undoubtedly accelerate the progress of these
types of solutions for the biopharma industry.”
Schuette noted that the high separation power of Agilent’s 2D-LC
technology makes it ideal for the analysis of highly complex
biopharmaceuticals, whether used for comprehensive screening or
detailed determination of specific peptides.
The Agilent Technologies Thought Leader Award promotes
fundamental scientific advances by contributing financial support,
products and expertise to the research of influential thought
leaders in the life sciences, diagnostics and applied chemical
markets. Information about previous award recipients is available
by visiting the Agilent Thought Leader Program web page.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in
life sciences, diagnostics and applied chemical markets, is the
premier laboratory partner for a better world. Agilent works with
customers in more than 100 countries, providing instruments,
software, services and consumables for the entire laboratory
workflow. The company generated revenues of $4.20 billion in fiscal
2016 and employs about 12,500 people worldwide. Information about
Agilent is available at www.agilent.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170419006000/en/
Agilent TechnologiesVictoria Wadsworth-Hansen, +1
408-553-2005+45 29 33 69
80victoria.wadsworth-hansen@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024